Notice of Closed Meeting, 67480-67481 [2022-24280]
Download as PDF
<![CDATA[
67480
Federal Register / Vol. 87, No. 215 / Tuesday, November 8, 2022 / Notices
PICOTS (POPULATIONS, INTERVENTIONS, COMPARATORS, OUTCOMES, AND SETTINGS)—Continued
Inclusion
Timing .......................
Settings ....................
Study designs and
publication types.
Exclusion
KQ 2:
• RMC provider knowledge and/or practices.
• Rates of procedures and interventions.
KQ 3:
• Health outcomes for pregnant persons.
Æ Maternal morbidity.
Æ Maternal mortality.
Æ Mental health outcomes.
Æ Function, quality of life, patient satisfaction using
validated measures.
Æ Mental health outcomes based on validated measures (e.g., anxiety, depression).
Æ Harms.
• Utilization outcomes for pregnant persons.
Æ Length of stay.
Æ Healthcare utilization post-discharge.
Æ Rates of procedures.
KQ 4:
• Health outcomes for infants.
Æ Infant morbidity.
Æ Infant mortality.
Æ Harms.
• Utilization outcomes for infants.
Æ Length of stay.
Æ Healthcare utilization post-discharge.
• Intervention: Admission for labor through discharge after
delivery.
• Outcomes: from admission through one year postpartum
• KQ1, CQ: All countries in a hospital or birthing facility
setting (eg, birth centers).
• KQ 2–4: hospital or birthing facility in US or US relevant
countries.
• KQ 3c and 4c: hospital or birthing facility in US or US
relevant countries.
• KQ1–4: Trials (randomized and comparative nonrandomized), comparative observational studies.
Interventions: before labor, during prenatal care.
Outcomes: More than one year postpartum.
Home births.
KQ 1: Studies that do not describe psychometric properties/methods of determining validity of measures or
components.
KQ2–4: Case reports, case series (or similar single-arm
designs).
Publication types: Conference abstracts or proceedings,
editorials, letters, white papers, citations that have not
been peer-reviewed, single site reports of multi-site studies.
Abbreviations: CQ, contextual question; KQ, key question; RMC, respectful maternity care.
‘‘Disadvantaged persons’’ as defined by PROGRESS-plus framework.1
Reference
1. O’Neill J, Tabish H, Welch V, et al.
Applying an equity lens to interventions:
using PROGRESS ensures consideration
of socially stratifying factors to
illuminate inequities in health. J Clin
Epidemiol. 2014 Jan;67(1):56–64. doi:
10.1016/j.jclinepi.2013.08.005. PMID:
24189091.
Dated: November 2, 2022.
Marquita Cullom,
Associate Director.
lotter on DSK11XQN23PROD with NOTICES1
[FR Doc. 2022–24384 Filed 11–7–22; 8:45 am]
BILLING CODE 4160–90–P
VerDate Sep<11>2014
16:56 Nov 07, 2022
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Name of Committee: Safety and
Occupational Health Study Section (SOHSS),
National Institute for Occupational Safety
and Health (NIOSH).
Dates: February 7–8, 2023.
Times: 11:00 a.m.–5:00 p.m., EST.
Place: Teleconference.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the Study
Section to consider safety and occupational
health-related grant applications.
For Further Information Contact: Michael
Goldcamp, Ph.D., Scientific Review Officer,
NIOSH, 1095 Willowdale Road, Morgantown,
West Virginia 26506; Telephone: (304) 285–
5951; Email: MGoldcamp@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
E:\FR\FM\08NON1.SGM
08NON1
67481
Federal Register / Vol. 87, No. 215 / Tuesday, November 8, 2022 / Notices
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–24280 Filed 11–7–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request; Information
Collection Request Title: Maternal,
Infant, and Early Childhood Home
Visiting Program Home Visiting Budget
Assistance Tool
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than January 9, 2023.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N39, 5600 Fishers
Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Samantha Miller, the acting
SUMMARY:
HRSA Information Collection Clearance
Officer, at (301) 443–9094.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the ICR title
for reference.
Information Collection Request Title:
Maternal, Infant, and Early Childhood
Home Visiting (MIECHV) Program
Home Visiting Budget Assistance Tool,
OMB No. 0906–0025–Revision.
Abstract: HRSA is requesting
continued approval and revision to the
Home Visiting Budget Assistance Tool
(HV–BAT). The tool collects
information on standardized cost
metrics from programs that deliver
home visiting services, as outlined in
the HV–BAT. Entities receiving
MIECHV formula funds that are states,
jurisdictions, and nonprofit awardees
are required to submit cost data using
the HV–BAT to HRSA once every 3
years to be reviewed for accuracy and
quality control and to collect data to
estimate national program costs.
The MIECHV Program, authorized by
section 511 of the Social Security Act,
42 U.S.C. 711, and administered by
HRSA in partnership with the
Administration for Children and
Families, supports voluntary, evidencebased home visiting services during
pregnancy and for parents with young
children up to kindergarten entry.
States, Tribal entities, and certain
nonprofit organizations are eligible to
receive funding from the MIECHV
Program and have the flexibility to tailor
the program to serve the specific needs
of their communities. Funding
recipients may subaward grant funds to
local implementing agencies (LIA) in
order to provide services to eligible
families in at-risk communities. HRSA
is making the following changes to the
HV–BAT:
• Updating the burden estimate for
completing the HV–BAT based on
recently gathered information, and
• Translating the HV–BAT data
collection instrument into Spanish to
expand accessibility.
Need and Proposed Use of the
Information: HRSA uses HV–BAT data
to collect comprehensive home visiting
cost data. Awardees submit aggregated
data from their individual LIA, which
provides HRSA with information
needed to produce state and national
cost estimates and support procurement
activities and subrecipient monitoring.
Requiring data submission also allows
HRSA to ensure the tool is being
accurately and appropriately used.
Because the use of a standardized tool
of this kind is novel to the field of home
visiting, HRSA requires that states
submit data collected using the HV–
BAT to HRSA for the purposes of
quality control reviews and accuracy
checks. Submission will allow HRSA to
estimate national-level costs for use in
conducting research and analysis of
home visiting costs, understanding cost
variation, and assessing how
comprehensive program cost data can
inform other policy priorities, such as
innovative financing strategies. HRSA is
seeking to revise burden estimates to
ensure accuracy and inform awardee
planning for this activity. In addition,
HRSA is translating the HV–BAT data
collection instrument into Spanish in
response to awardee feedback and to
increase accessibility for LIA sites that
primarily operate in Spanish.
Likely Respondents: One-third of
MIECHV Program awardees (n=19,
annually) that are states, jurisdictions,
and, nonprofit organizations receiving
MIECHV funding to provide home
visiting services within states.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
lotter on DSK11XQN23PROD with NOTICES1
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Total
responses
Average
burden
per response
(in hours)
Total burden
hours
Home Visiting Budget Assistance Tool (HV–BAT) ..............
19
13
247
24
5,928
Total ..............................................................................
19
13
247
24
5,928
VerDate Sep<11>2014
16:56 Nov 07, 2022
Jkt 259001
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
E:\FR\FM\08NON1.SGM
08NON1
]]>Agencies
[Federal Register Volume 87, Number 215 (Tuesday, November 8, 2022)]
[Notices]
[Pages 67480-67481]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24280]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463.
Name of Committee: Safety and Occupational Health Study Section
(SOHSS), National Institute for Occupational Safety and Health
(NIOSH).
Dates: February 7-8, 2023.
Times: 11:00 a.m.-5:00 p.m., EST.
Place: Teleconference.
Agenda: The meeting will convene to address matters related to
the conduct of Study Section business and for the Study Section to
consider safety and occupational health-related grant applications.
For Further Information Contact: Michael Goldcamp, Ph.D.,
Scientific Review Officer, NIOSH, 1095 Willowdale Road, Morgantown,
West Virginia 26506; Telephone: (304) 285-5951; Email:
[email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to
[[Page 67481]]
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-24280 Filed 11-7-22; 8:45 am]
BILLING CODE 4163-18-P
